Request for Information, Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings
What happened
On April 18, 2026, President Trump issued Executive Order (E.O.) 14401, "Accelerating Medical Treatments for Serious Mental Illness." Following this, the Health Resources & Services Administration (HRSA) is requesting information from the public by August 13, 2026, on training and care models for delivering future FDA-approved psychedelic drugs in outpatient settings like health centers.
Why it matters
This aims to ensure that if psychedelic drugs are approved by the FDA for mental illness, there are safe and effective ways to provide them, especially in underserved communities. It could shape how these new treatments are integrated into healthcare, including what training providers need.
Who it affects
- ›Individuals with serious mental illness
- ›Healthcare providers and clinicians
- ›Rural health clinics and health centers
- ›Stakeholders in psychedelic therapy
The receipts are official. The summary is ours.
Read on Federal Register ↗Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.